Agilent Technologies, Inc.: updates and filings

ANYSEHealthcare · Laboratory Analytical Instruments

Price

$172.41

November 17, 2026Market cap $48.9B

What Ploutos Investor adds for Agilent Technologies

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 9 daysAround Nov 26, 2026 · for Q4 2026

last Aug 26, 2026next Nov 26, 2026

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Dec 22, 2025 latest annualSep 1, 2026 latest quarterly
  • Sep 23, 2026Filing
    FormEFFECT
  • Sep 8, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Sep 1, 2026Filing
    FormS-4
  • Sep 1, 2026Shelf registration for future offerings
    FormS-3ASR
  • Sep 1, 2026Quarterly reportfor the period to Jul 31, 2026
    Form10-Q
  • Aug 26, 2026Results of operations
    Form8-K
  • Jun 25, 2026Material agreement entered, new material financial obligation
    Form8-K
  • Jun 1, 2026Quarterly reportfor the period to Apr 30, 2026
    Form10-Q
  • May 29, 2026Conflict minerals report
    FormSD
  • May 27, 2026Results of operations, officer or director change
    Form8-K
  • May 4, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Apr 29, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 28, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 6, 2026Officer or director change (amendment)
    Form8-K/A
  • Apr 3, 2026Change in control
    Form8-K
  • Mar 26, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 20, 2026Amended articles or bylaws, shareholder vote
    Form8-K
  • Mar 6, 2026Officer or director change
    Form8-K
  • Mar 3, 2026Quarterly reportfor the period to Jan 31, 2026
    Form10-Q
  • Feb 25, 2026Results of operations
    Form8-K
  • Feb 6, 2026Additional annual meeting material
    FormDEFA14A
  • Feb 6, 2026Annual report to shareholdersfor the period to Oct 31, 2025
    FormARS
  • Feb 6, 2026Annual meeting proxy statement
    FormDEF 14A
  • Jan 23, 2026Preliminary proxy statement
    FormPRE 14A
  • Dec 22, 2025Annual reportfor the period to Oct 31, 2025
    Form10-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Aug 16, 1999.

The full analysis

What do Agilent Technologies's filings show?

The filings are where every one of Agilent Technologies's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.